Morgan Stanley acted as lead book running manager for the offering.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IMMX:
- Immix Biopharma announces phase 2 NXC-201 results
- Immix Biopharma Updates Accounting Firm Consents
- Immix Biopharma appoints Grabow as Chief Commercial Officer
- Immix Biopharma: Promising Trial Results and Strong Financial Position Justify Buy Rating
- Immix Biopharma’s NXC-201 CAR-T Study: A Potential Game-Changer for AL Amyloidosis